West Pharmaceutical Services Stock Performance
| WST Stock | USD 247.90 4.29 1.76% |
The firm maintains a market beta of 1.68, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, West Pharmaceutical will likely underperform. At this point, West Pharmaceutical has a negative expected return of -0.0976%. Please make sure to check out West Pharmaceutical's value at risk and rate of daily change , to decide if West Pharmaceutical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days West Pharmaceutical Services has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, West Pharmaceutical is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Actual Historical Performance (%)
One Day Return (1.04) | Five Day Return 3.5 | Year To Date Return (11.86) | Ten Year Return 341.48 | All Time Return 21.8 K |
Forward Dividend Yield 0.0036 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 0.88 | Dividend Date 2026-02-04 |
1 | Insider Trading | 11/18/2025 |
| West Pharmaceutical dividend paid on 19th of November 2025 | 11/19/2025 |
2 | Acquisition by Norman Finch of 192 shares of West Pharmaceutical subject to Rule 16b-3 | 12/08/2025 |
3 | Acquisition by Haugen Janet Brutschea of tradable shares of West Pharmaceutical subject to Rule 16b-3 | 12/31/2025 |
4 | All You Need to Know About West Pharmaceutical Rating Upgrade to Strong Buy | 01/22/2026 |
5 | Is West Pharmaceutical Refocusing on Larger-Volume SmartDose a Quiet Shift in Its Strategic Moat | 01/29/2026 |
6 | Heres Why West Pharmaceutical Is a Great Buy the Bottom Stock Now | 01/30/2026 |
| West Pharmaceutical dividend paid on 4th of February 2026 | 02/04/2026 |
8 | Pharmaceutical Packaging Market Poised for 8.8 percent CAGR Through 2036 as Safety and Compliance Drive Demand | 02/06/2026 |
9 | Countdown to West Pharmaceutical Q4 Earnings A Look at Estimates Beyond Revenue and EPS | 02/10/2026 |
| Begin Period Cash Flow | 853.9 M | |
| Total Cashflows From Investing Activities | -378.7 M |
West Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 26,217 in West Pharmaceutical Services on November 15, 2025 and sell it today you would lose (1,856) from holding West Pharmaceutical Services or give up 7.08% of portfolio value over 90 days. West Pharmaceutical Services is generating negative expected returns assuming volatility of 2.2434% on return distribution over 90 days investment horizon. In other words, 20% of stocks are less volatile than West, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
West Pharmaceutical Target Price Odds to finish over Current Price
The tendency of West Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 247.90 | 90 days | 247.90 | about 84.7 |
Based on a normal probability distribution, the odds of West Pharmaceutical to move above the current price in 90 days from now is about 84.7 (This West Pharmaceutical Services probability density function shows the probability of West Stock to fall within a particular range of prices over 90 days) .
West Pharmaceutical Price Density |
| Price |
Predictive Modules for West Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as West Pharmaceutical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of West Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
West Pharmaceutical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. West Pharmaceutical is not an exception. The market had few large corrections towards the West Pharmaceutical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold West Pharmaceutical Services, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of West Pharmaceutical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.26 | |
β | Beta against Dow Jones | 1.68 | |
σ | Overall volatility | 15.52 | |
Ir | Information ratio | -0.1 |
West Pharmaceutical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of West Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for West Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| West Pharmaceutical generated a negative expected return over the last 90 days | |
| Over 98.0% of the company outstanding shares are owned by institutional investors | |
| On 4th of February 2026 West Pharmaceutical paid $ 0.22 per share dividend to its current shareholders | |
| Latest headline from thelincolnianonline.com: Insider Trading |
West Pharmaceutical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of West Stock often depends not only on the future outlook of the current and potential West Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. West Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 73.7 M | |
| Cash And Short Term Investments | 484.6 M |
West Pharmaceutical Fundamentals Growth
West Stock prices reflect investors' perceptions of the future prospects and financial health of West Pharmaceutical, and West Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on West Stock performance.
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.1 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 17.38 B | ||||
| Shares Outstanding | 71.94 M | ||||
| Price To Earning | 40.71 X | ||||
| Price To Book | 5.80 X | ||||
| Price To Sales | 5.87 X | ||||
| Revenue | 2.89 B | ||||
| Gross Profit | 1.07 B | ||||
| EBITDA | 743.8 M | ||||
| Net Income | 492.7 M | ||||
| Cash And Equivalents | 484.6 M | ||||
| Cash Per Share | 9.85 X | ||||
| Total Debt | 305.3 M | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 3.80 X | ||||
| Book Value Per Share | 42.44 X | ||||
| Cash Flow From Operations | 653.4 M | ||||
| Earnings Per Share | 6.74 X | ||||
| Market Capitalization | 17.71 B | ||||
| Total Asset | 3.64 B | ||||
| Retained Earnings | 3.96 B | ||||
| Working Capital | 987.7 M | ||||
| Current Asset | 673.7 M | ||||
| Current Liabilities | 314.3 M | ||||
About West Pharmaceutical Performance
Assessing West Pharmaceutical's fundamental ratios provides investors with valuable insights into West Pharmaceutical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the West Pharmaceutical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 65.51 | 52.07 | |
| Return On Tangible Assets | 0.14 | 0.13 | |
| Return On Capital Employed | 0.17 | 0.10 | |
| Return On Assets | 0.12 | 0.13 | |
| Return On Equity | 0.17 | 0.10 |
Things to note about West Pharmaceutical performance evaluation
Checking the ongoing alerts about West Pharmaceutical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for West Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| West Pharmaceutical generated a negative expected return over the last 90 days | |
| Over 98.0% of the company outstanding shares are owned by institutional investors | |
| On 4th of February 2026 West Pharmaceutical paid $ 0.22 per share dividend to its current shareholders | |
| Latest headline from thelincolnianonline.com: Insider Trading |
- Analyzing West Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether West Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining West Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating West Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of West Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of West Pharmaceutical's stock. These opinions can provide insight into West Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for West Stock Analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.